HRMY
Harmony Biosciences Holdings, Inc. Common Stock
stockNASDAQ
patients are at the beginning, middle, and heart of all we do. harmony biosciences, llc, is a privately-owned biopharmaceutical company. the company was established in october 2017 with a vision to provide novel treatment options for people living with rare and orphan diseases with an emphasis on central nervous system disorders, starting with a focus on helping patients who live with narcolepsy. harmony biosciences is committed to advancing the understanding of narcolepsy and providing information and resources to individuals who live with, and healthcare professionals who treat, patients with narcolepsy.
| Period | Price | Date | Change | Beta |
|---|---|---|---|---|
| 1W | 40.01 | 2026-09-28 | -0.93% | 1.263 |
| 1M | 42.25 | 2026-09-04 | -6.18% | 1.034 |
| 3M | 37.01 | 2026-07-06 | +7.11% | 0.902 |
| 6M | 27.71 | 2026-04-06 | +43.05% | 0.256 |
| 1Y | 27.28 | 2025-10-03 | +45.31% | 0.515 |
| 2Y | 34.60 | 2024-10-04 | +14.57% | — |
| 5Y | 37.18 | 2021-10-04 | +6.62% | 0.785 |
Harmony Biosciences Holdings, Inc. Common Stock (NASDAQ:HRMY) stock price today is $39.64, and today's volume is 916,734. HRMY is up 0.177% today. The 30 day average volume is 966,183. HRMY market cap is $2.31B with 58.24M shares outstanding.